Search PubMed⌕ Search

PubMed · 16214607

Fast frequency selective MR imaging.

Abstract

With the proposed fast frequency selective MR imaging (FFSMRI) method, we focused on the elimination of all off-resonance components from the image of the observed object. To maintain imaging speed and simultaneously achieve good frequency selectivity, MRI was divided into two steps: signal acquisition and postprocessing. After the preliminary phase in which we determine imaging parameters, MRI takes place; the signal from the same object is successively acquired M times. As a result, we obtain M partial signals in k-space, from which we calculate the image of the observed object in postprocessing phase, after signal acquisition has been completed. With proper selection of parameters, it is possible to exclude from the image a majority of off-resonance components present in the observed object. However, we can decide to keep only a chosen off-resonance component in the image and eliminate all other components, including the on-resonance component and thus producing a different image from the same acquisition. The experiments with Fe(OH)(3) and oil showed that signal-to-noise ratio (SNR) can be improved by about a factor of four. The proposed FFSMRI method is suitable for frequency selective MR imaging and quantitative measurements in dynamic MRI where exclusion of off-resonance components can improve the reliability of measurement.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jure Medic, Saso Tomazic, Franci Demsar. 2005-09-09. Fast frequency selective MR imaging.. https://doi.org/10.1016/j.mri.2005.06.006

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Striping artifact removal in VisiumHD data through nuclear counts modeling.

MOTIVATION: 10x Genomics VisiumHD enables spatial transcriptomics at 2 µm × 2 µm resolution but exhibits slide-specific, non-periodic striping artifacts due to lane-width variability. These multiplicative row/column effects distort bin total counts and can bias downstream analyses. The state-of-the-art destriping approach is the normalization procedure used as a preprocessing step in bin2cell; it applies sequential high-quantile row- then column-wise normalization, which is asymmetric and can introduce edge effects/macro-stripes and distortions of large-scale total-count structure. RESULTS: We propose a statistical destriping approach that leverages nuclei segmentation from the co-registered H&E image. Assuming transcript abundance is constant within each nucleus, we model bin counts with a negative binomial distribution whose mean is a product of a nucleus-specific concentration and row- and column-specific stripe-factors reflecting lane-width variation. We fit all parameters in a generalized linear modeling framework with cross-validated regularization on stripe-factors and iterative dispersion estimation, and use the fitted parameters to correct the observed counts into a destriped image. On synthetic data with known ground truth, our method improves stripe-factor estimation accuracy and reduces error in corrected counts relative to bin2cell and bin2cell-derived baselines. Across four public VisiumHD slides, it consistently lowers striping intensity while substantially better preserving biological signal present in the large-scale global count structure and avoiding the artifacts introduced by other methods. AVAILABILITY AND IMPLEMENTATION: All source code and links to publicly available data used for this study are available at https://github.com/paolamalsot/destriping-GLM.

Artifacts↗

Cleavage of cystatin C is not associated with multiple sclerosis.

Recently, Irani and colleagues proposed a C-terminal cleaved isoform cystatin C (12.5 kDa) in cerebrospinal fluid as a marker of multiple sclerosis. In this study, we demonstrate that the 12.5 kDa product of cystatin C is formed by degradation of the first eight N-terminal residues. Moreover, such a degradation is not specific in the cerebrospinal fluid of multiple sclerosis, but rather is given by an inappropriate sample storage at -20 degrees C. We conclude that the use of the 12.5 kDa product of cystatin C in cerebrospinal fluid might lead to a fallacious diagnosis of multiple sclerosis. Preanalytical validation procedure is mandatory for proteomics investigations.

Artifacts↗